Cite
MLA Citation
F. Janku et al.. “Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor.” European journal of cancer, vol. 138, n.d., pp. S2–S3. http://access.bl.uk/ark:/81055/vdc_100120046953.0x000024